SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001546927-15-000285
Filing Date
2015-11-23
Accepted
2015-11-23 16:48:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 opal13gprotalixfiled.txt SC 13G 13586
  Complete submission text file 0001546927-15-000285.txt   15296
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 151250228
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110
Business Address 175 FEDERAL STREET, 6TH FLOOR BOSTON MA 02110 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G